Home Cart 0 Sign in  
X

[ CAS No. 40473-01-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 40473-01-6
Chemical Structure| 40473-01-6
Chemical Structure| 40473-01-6
Structure of 40473-01-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 40473-01-6 ]

Related Doc. of [ 40473-01-6 ]

Alternatived Products of [ 40473-01-6 ]

Product Details of [ 40473-01-6 ]

CAS No. :40473-01-6 MDL No. :MFCD00234006
Formula : C5H3BrClN Boiling Point : -
Linear Structure Formula :- InChI Key :BZUUVQCSPHPUQA-UHFFFAOYSA-N
M.W : 192.44 Pubchem ID :817098
Synonyms :

Calculated chemistry of [ 40473-01-6 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 36.95
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.73 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.92
Log Po/w (XLOGP3) : 2.46
Log Po/w (WLOGP) : 2.5
Log Po/w (MLOGP) : 1.85
Log Po/w (SILICOS-IT) : 2.76
Consensus Log Po/w : 2.3

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.14
Solubility : 0.14 mg/ml ; 0.000728 mol/l
Class : Soluble
Log S (Ali) : -2.37
Solubility : 0.812 mg/ml ; 0.00422 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.5
Solubility : 0.0614 mg/ml ; 0.000319 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.78

Safety of [ 40473-01-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302+H312+H332-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 40473-01-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 40473-01-6 ]
  • Downstream synthetic route of [ 40473-01-6 ]

[ 40473-01-6 ] Synthesis Path-Upstream   1~19

  • 1
  • [ 1072-98-6 ]
  • [ 40473-01-6 ]
YieldReaction ConditionsOperation in experiment
93% With hydrogen bromide; bromine; sodium nitrite In water at 0 - 10℃; for 1.5 h; Bromine (26 ml, 0.52 mol)was added to a solution of 2-amino-5-chloropyridine (2)(25.6 g, 0.2 mol) in 48percent HBr solution (100 ml, 1.2 mol),while maintaining the temperature at solution of sodium nitrite (32.4 g, 0.47 mol) in water(50 ml) was added over 1 h at the same temperature. Afterthe addition was complete, the reaction mixture was stirredfor additional 30 min and then treated with a solution ofNaOH (74.6 g, 1.86 mol) in water (100 ml) at such a ratethat the temperature did not exceed 20–25°C. The obtainedprecipitate was filtered off, washed with a saturatedsolution of NaHSO3 (~5 ml), several times with ice water(3×30 ml), and air-dried. Yield 35.6 g (93percent), beige powder,mp 67–68° (hexane) (mp 68–69°10). Rf -0.4 (CHCl3).1H NMR spectrum (CDCl3), δ, ppm (J, Hz): 7.44 (1H, d,J = 8.4, H-3); 7.54 (1, dd, J = 8.4, J = 2.6, H-4); 8.35(1H, d, J = 2.6, H-6). 13C NMR spectrum (CDCl3), δ, ppm:128.7; 131.5; 138.1; 139.2; 148.6.
91%
Stage #1: With hydrogen bromide; bromine; sodium nitrite In water at 0℃; for 1 h;
Stage #2: With sodium hydroxide In water; ethyl acetate
[Referential Example 25] 5-(5-Chloro-2-pyridyl)-1-(3-pyridyl)-1H-pyrazole-3-carboxylic acid; [Show Image] 1) 2-Bromo-5-chloropyridine Bromine (12 ml) was added to a solution of 2-amino-5-chloropyridine (5g) in 47percent hydrobromic acid (50 ml) at 0°C, and a solution of sodium nitrite (15 g) in water (20 ml) was added dropwise to this reaction liquid. After stirring the mixture for 1 hour, a solution of sodium hydroxide (32 g) in water (80 ml) and ethyl acetate to the reaction liquid, and the phases were separated. The organic layer was dried over anhydrous sodium sulfate. After filtration, the solvent was evaporated under reduced pressure to give 2-bromo-5-chloropyridine (6.8 g, 91percent) as a solid. 1H-NMR (400 MHz, CDCl3)δ: 7.44 (1H, d, J = 8.42 Hz), 7.54 (1H, m), 8.36 (1H, s).
91% With hydrogen bromide; bromine; sodium nitrite In water at 0℃; for 1 h; 1)
2-Bromo-5-chloropyridine
At 0°C, bromine (12 mL) was added to 2-amino-5-chloropyridine (5 g) in 47percent hydrobromic acid (50 mL), and then sodium nitrite (15 g) in water (20 mL) was added dropwise to the reaction mixture, followed by stirring for 1 hour.
The reaction mixture was partitioned between sodium hydroxide (32 g) in water (80 mL) and ethyl acetate.
The organic layer was dried over sodium sulfate anhydrate.
After a filtration step, the solvent was evaporated under reduced pressure, to thereby give 2-bromo-5-chloropyridine as a solid product (6.8 g, 91percent).
1H-NMR(400MHz,CDCl3)δ:7.44(1H,d,J=8.42Hz), 7.54(1H,m), 8.36(1H,s).
87% With bromine; sodium nitrite In water; hydrogen bromide (1)
2-Bromo-5-chloropyridine
To a solution of 2-amino-5-chloropyridine (15.0 g) in 47percent hydrobromic acid (18 ml) was gradually added dropwise bromine (18 ml) under ice-cooling.
After the dropwise addition, a solution of sodium nitrite (20.1 g) in water (100 ml) was gradually added dropwise under ice-cooling, and the mixture was stirred for 1 hour.
The solution was adjusted to pH 8 with a 5N aqueous sodium hydroxide solution and extracted with ether, washed with an aqueous sodium nitrite solution and water, and dried over magnesium sulfate.
The solvent was distilled away under reduced pressure to give 19.5 g of a pale-brown solid (yield 87percent).
IR (KBr): 3000, 1550 cm-1
1 H-NMR (CDCl3) δ: 7.43(1H, d, J=8.0 Hz), 7.54(1H, dd, J=8.0, 3.0 Hz), 8.35(1H, d, J=3.0 Hz)
85% With hydrogen bromide; bromine; sodium nitrite In water at -5 - 15℃; 2-Amino-5-chloropyridine (3.86 g, 30.0 mmol) was dissolved in 48percent HBr (50 mL). To this solution was added bromine (4.61 mL), while the inside temperature was kept from -5 °C to 0 °C. After water (25 mL) containing sodium nitrite (5.18 g, 75.0 mmol) was slowly added to the mixture, inside temperature was slowly raised to 15 °C while stirring the mixture for 3 h. To the solution were added 5 M NaOH aqueous solution (150 mL), sodium thiosulfate aqueous solution (10 mL) and Et2O (150 mL). Organic layer was separated, washed with brine and dried over Na2SO4. Solvent was distilled off in vacuo to obtain the title compound (4.90 g, 25.5 mmol, 85percent) as a yellow solid. 1H NMR (CDCl3) δ: 7.44 (1H, dd, J = 8.5, 0.7 Hz), 7.53 (1H, dd, J = 8.3, 2.7 Hz), 8.35 (1H, dd, J = 2.7, 0.7 Hz).

Reference: [1] Chemistry of Heterocyclic Compounds, 2017, vol. 53, # 2, p. 196 - 206[2] Khim. Geterotsikl. Soedin., 2017, vol. 53, # 2, p. 196 - 206,11
[3] Patent: EP1698626, 2006, A1, . Location in patent: Page/Page column 41
[4] Patent: EP1762568, 2007, A1, . Location in patent: Page/Page column 24-25
[5] Patent: US5750545, 1998, A,
[6] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 5, p. 1623 - 1642
[7] Journal of the American Chemical Society, 1946, vol. 68, p. 2574,2576
[8] Patent: WO2005/99711, 2005, A1, . Location in patent: Page/Page column 22; 41-42
[9] Patent: US4457927, 1984, A,
[10] Patent: WO2005/100349, 2005, A2, . Location in patent: Page/Page column 49-50
[11] Patent: US2005/239800, 2005, A1, . Location in patent: Page/Page column 10; 19
[12] Patent: US2009/253708, 2009, A1, . Location in patent: Page/Page column 11-12
  • 2
  • [ 1072-98-6 ]
  • [ 40473-01-6 ]
  • [ 2516-40-7 ]
Reference: [1] Patent: US4510148, 1985, A,
  • 3
  • [ 16110-09-1 ]
  • [ 40473-01-6 ]
Reference: [1] European Journal of Organic Chemistry, 2002, # 24, p. 4181 - 4184
  • 4
  • [ 4214-79-3 ]
  • [ 40473-01-6 ]
Reference: [1] Patent: US2003/236270, 2003, A1, . Location in patent: Page 44
  • 5
  • [ 40473-01-6 ]
  • [ 89809-64-3 ]
Reference: [1] Patent: WO2010/132615, 2010, A1, . Location in patent: Page/Page column 131-132
  • 6
  • [ 40473-01-6 ]
  • [ 124-38-9 ]
  • [ 86873-60-1 ]
YieldReaction ConditionsOperation in experiment
9.6%
Stage #1: With n-butyllithium In diethyl ether; hexane at -78℃; for 2 h; Inert atmosphere
Stage #2: for 2 h;
Compound 17 (4.54 g, 23.6 mmol) was suspended in dried Et2O (100 mL) under argon atmosphere. To the suspension was added 1.54 M n-butyllithium solution in hexane (16.9 mL, 26.0 mmol) at -78 °C, and the mixture was stirred for 2 h to obtain a brown solution. Carbon dioxide gas (ca. 2 L) was blown into the solution, and the mixture was stirred for 2 h. After warming to room temperature, the solvent was distilled off in vacuo. Obtained brown solid was washed with hexane and suspended in water (50 mL). After 1 M HCl (30 mL) was added to this suspension, the mixture was concentrated in vacuo. Obtained yellow solid was washed with Et2O to obtain the title compound (358 mg, 2.27 mmol, 9.6percent) as a yellow solid. 1H NMR (DMSO-d6) δ: 8.05 (2H, d, J = 8.4 Hz), 8.12 (1H, dd, J = 8.4, 2.3 Hz), 8.76 (1H, d, J = 2.3 Hz). ESI-MS m/z: 158 [(M+H)+, 35Cl], 160 [(M+H)+, 37Cl].
Reference: [1] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 5, p. 1623 - 1642
  • 7
  • [ 1072-98-6 ]
  • [ 40473-01-6 ]
  • [ 2516-40-7 ]
Reference: [1] Patent: US4510148, 1985, A,
  • 8
  • [ 40473-01-6 ]
  • [ 67-56-1 ]
  • [ 201230-82-2 ]
  • [ 132308-19-1 ]
YieldReaction ConditionsOperation in experiment
93% at 50℃; for 24 h; To a solution of 2-bromo-5-chloropyridine (30.0 g, 155.9 mmol) in MeOH (280 mL) was added Pd(OAc)2 (3.5 g, 10.8 mmol), dppf (17.3 g, 37.96 mmol), Et3N (42.0 mL, 312 mmol). The resulting mixture was stirred at 500C under a CO atmosphere (15 psi) for 24 h, then concentrated under reduced pressure to give crude residue. This residue was partitioned between EtOAc (3 X 500 mL) and water (300 mL). The combined organic layers were dried (Na2SO4) and evaporated. Flash chromatography of the residue over silica gel, by using 10:1 petroleum ether/EtOAc, afforded the title compound as a pale yellow solid (25 g, 93percent): 1H NMR (400 MHz, CDCI3) δ ppm 8.60 (d, J = 1.60 Hz, 1 H), 8.01 (d, J = 8.40 Hz, 1 H), 7.75 (dd, J = 8.40, 2.40 Hz, 1 H), 3.92 (s, 3 H).
93% at 50℃; for 24 h; Intermediate 1 : methyl δ-chloro^-pyridinecarboxylate To a solution of 2-bromo-5-chloropyridine (30.0 g, 155.9 mmol) in MeOH (280 ml.) was added Pd(OAc)2 (3.5 g, 10.8 mmol), dppf (17.3 g, 37.96 mmol), Et3N (42.0 ml_, 312 mmol). The resulting mixture was stirred at 500C under a CO atmosphere (15 psi) for 24 h, then concentrated under reduced pressure to give crude residue. This residue was partitioned between EtOAc (3 X 500 ml.) and water (300 ml_). The combined organic layers were dried (Na2SO4) and evaporated. Flash chromatography of the residue over silica gel, by using 10:1 petroleum ether/EtOAc, afforded the title compound as a pale yellow solid (25 g, 93percent): 1H NMR (400 MHz, CDCI3) δ ppm 8.60 (d, J = 1.60 Hz, 1 H), 8.01 (d, J = 8.40 Hz, 1 H), 7.75 (dd, J = 8.40, 2.40 Hz, 1 H), 3.92 (s, 3H).
93% at 50℃; for 24 h; Intermediate 1 : methyl δ-chloro^-pyridinecarboxylate To a solution of 2-bromo-5-chloropyridine (30.0 g, 155.9 mmol) in MeOH (280 ml.) was added Pd(OAc)2 (3.5 g, 10.8 mmol), dppf (17.3 g, 37.96 mmol), Et3N (42.0 ml_, 312 mmol). The resulting mixture was stirred at 500C under a CO atmosphere (15 psi) for 24 h, then concentrated under reduced pressure to give crude residue. This residue was partitioned between EtOAc (3 X 500 ml.) and water (300 ml_). The combined organic layers were dried (Na2SO4) and evaporated. Flash chromatography of the residue over silica gel, by using 10:1 petroleum ether/EtOAc, afforded the title compound as a pale yellow solid (25 g, 93percent): 1H NMR (400 MHz, CDCI3) δ ppm 8.60 (d, J = 1.60 Hz, 1 H), 8.01 (d, J = 8.40 Hz, 1 H), 7.75 (dd, J = 8.40, 2.40 Hz, 1 H), 3.92 (s, 3H).
93% at 50℃; for 24 h; Intermediate 1 : methyl δ-chloro^-pyridinecarboxylate To a solution of 2-bromo-5-chloropyridine (30.0 g, 155.9 mmol) in MeOH (280 ml.) was added Pd(OAc)2 (3.5 g, 10.8 mmol), dppf (17.3 g, 37.96 mmol), Et3N (42.0 ml_, 312 mmol). The resulting mixture was stirred at 500C under a CO atmosphere (15 psi) for 24 h, then concentrated under reduced pressure to give crude residue. This residue was partitioned between EtOAc (3 X 500 ml.) and water (300 ml_). The combined organic layers were dried (Na2SO4) and evaporated. Flash chromatography of the residue over silica gel, by using 10:1 petroleum ether/EtOAc, afforded the title compound as a pale yellow solid (25 g, 93percent): 1H NMR (400 MHz, CDCI3) δ ppm 8.60 (d, J = 1.60 Hz, 1 H), 8.01 (d, J = 8.40 Hz, 1 H), 7.75 (dd, J = 8.40, 2.40 Hz, 1 H), 3.92 (s, 3H).
93% at 50℃; for 24 h; Intermediate 1 : methyl δ-chloro^-pyridinecarboxylateTo a solution of 2-bromo-5-chloropyridine (30.0 g, 155.9 mmol) in MeOH (280 ml.) was added Pd(OAc)2 (3.5 g, 10.8 mmol), dppf (17.3 g, 37.96 mmol), Et3N (42.0 ml_, 312 mmol). The resulting mixture was stirred at 500C under a CO atmosphere (15 psi) for 24 h, then concentrated under reduced pressure to give crude residue. This residue was partitioned between EtOAc (3 X 500 ml.) and water (300 ml_). The combined organic layers were dried (Na2SO4) and evaporated. Flash chromatography of the residue over silica gel, by using 10:1 petroleum ether/EtOAc, afforded the title compound as a pale yellow solid (25 g, 93percent): 1H NMR (400 MHz, CDCI3) δ ppm 8.60 (d, J = 1.60 Hz, 1 H), 8.01 (d, J = 8.40 Hz, 1 H), 7.75 (dd, J = 8.40, 2.40 Hz, 1 H), 3.92 (s, 3H).
93% at 50℃; for 24 h; I. methyl 5-chloro-2-pyridinecarboxylate To a solution of 2-bromo-5-chloropyridine (30.0 g, 155.9 mmol) in MeOH (280 mL) was added Pd(OAc)2 (3.5 g, 10.8 mmol), dppf (17.3 g, 37.96 mmol), Et3N (42.0 mL, 312 mmol). The resulting mixture was stirred at 50°C under a CO atmosphere (15 psi) for 24 h, then concentrated under reduced pressure to give crude residue. This residue was partitioned between EtOAc (3 X 500 mL) and water (300 mL). The combined organic layers were dried (Na2SC>4) and evaporated. Flash chromatography of the residue over silica gel, by using 10: 1 petroleum ether/EtOAc, afforded the title compound as a pale yellow solid (25 g, 93percent yield): 1H NMR (400 MHz, CDC13) δ ppm 8.60 (d, J = 1.60 Hz, 1H), 8.01 (d, J= 8.40 Ηζ,ΙΗ), 7.75 (dd, J = 8.40, 2.40 Hz, 1H), 3.92 (s, 3H).

Reference: [1] Patent: WO2009/76387, 2009, A1, . Location in patent: Page/Page column 26
[2] Patent: WO2010/141538, 2010, A1, . Location in patent: Page/Page column 18
[3] Patent: WO2010/141539, 2010, A1, . Location in patent: Page/Page column 18
[4] Patent: WO2010/141545, 2010, A1, . Location in patent: Page/Page column 19
[5] Patent: WO2010/141540, 2010, A1, . Location in patent: Page/Page column 17
[6] Patent: WO2013/166621, 2013, A1, . Location in patent: Page/Page column 47
  • 9
  • [ 40473-01-6 ]
  • [ 349-94-0 ]
Reference: [1] Tetrahedron, 2004, vol. 60, # 51, p. 11869 - 11874
[2] Patent: US2011/306592, 2011, A1,
  • 10
  • [ 40473-01-6 ]
  • [ 27032-63-9 ]
YieldReaction ConditionsOperation in experiment
82% With hydrazine hydrate In isopropyl alcohol for 10 h; Reflux Hydrazine hydrate(45 ml, 0.9 mol) and 2-PrOH (45 ml) were added to 2-bromo-5-chloropyridine (3) (22.43 g, 0.117 mol), and the mixturewas refluxed for 10 h. The solvent was evaporated underreduced pressure, the obtained residue was suspended inwater (50 ml), filtered, washed with ice water (2×20 ml), and air-dried. Yield 13.78 g (82percent), white crystals, mp 124–125° (MeOH) (mp 123–125° (benzene)11). Rf 0.45(EtOAc–CHCl3, 1:1). 1H NMR spectrum (CDCl3), δ, ppm(J, Hz): 3.81 (2, br. s, NH2); 5.88 (1, br. s, NH); 6.71(1, d, J = 8.8, H-3); 7.45 (1, dd, J = 8.8, J = 2.3, H-4);8.07 (1H, d, J = 2.3, H-6). 13C NMR spectrum (CDCl3),δ, ppm: 107.3; 118.9; 135.9; 144.4; 158.8.
Reference: [1] Chemistry of Heterocyclic Compounds, 2017, vol. 53, # 2, p. 196 - 206[2] Khim. Geterotsikl. Soedin., 2017, vol. 53, # 2, p. 196 - 206,11
  • 11
  • [ 40473-01-6 ]
  • [ 68-12-2 ]
  • [ 31181-89-2 ]
Reference: [1] Patent: US2007/105904, 2007, A1, . Location in patent: Page/Page column 115
  • 12
  • [ 40473-01-6 ]
  • [ 807329-97-1 ]
  • [ 31181-89-2 ]
Reference: [1] Patent: US2009/143385, 2009, A1,
  • 13
  • [ 40473-01-6 ]
  • [ 209526-98-7 ]
Reference: [1] Patent: WO2013/166621, 2013, A1,
  • 14
  • [ 40473-01-6 ]
  • [ 64-17-5 ]
  • [ 201230-82-2 ]
  • [ 128072-93-5 ]
Reference: [1] Patent: EP1748048, 2007, A1, . Location in patent: Page/Page column 33
[2] Patent: US2003/236270, 2003, A1, . Location in patent: Page 44
  • 15
  • [ 40473-01-6 ]
  • [ 244221-57-6 ]
YieldReaction ConditionsOperation in experiment
75%
Stage #1: With acetyl chloride; sodium iodide In acetonitrile for 3 h; Heating / reflux
Stage #2: With potassium carbonate In water; acetonitrile at 0℃;
Preparation 1 5-Chloro-2-iodopyridineAcetyl chloride (11.05 ml_, 0.155 mol) was added to a solution of 2-bromo-5-chloropyridine (20.0 g, 0.103 mol) in acetonitrile (120 ml.) followed by sodium iodide (23.3 g, 0.155 mol) and the mixture was heated at reflux with a drying tube fitted for 3 hours. The reaction was cooled in an ice bath, carefully basified with saturated aqueous potassium carbonate then extracted with ethyl acetate (2 x 100 mL). The combined organic layers were washed with saturated aqueous sodium sulfite (200 mL), dried (MgSO4) and evaporated. The residue was then re-submitted to identical reaction and work-up conditions in order to ensure complete reaction and this gave the title compound (18.71 g, 75percent) as a brown solid. 1H NMR (CDCI3, 400 MHz) δ 7.30 (1H, dd), 7.65 (1H, d), 8.35 (1H, d); LRMS (APCI+) 240 [MH+].
75%
Stage #1: With acetyl chloride; sodium iodide In acetonitrile for 6 h; Heating / reflux
Stage #2: With potassium carbonate In water; acetonitrile at 0℃;
Preparation 60; 5-Chloro-2-iodopyridine; Acetyl chloride (11.05 mL, 0.155 mol) was adde Xd to? a solution of 2-bromo-5-chloropyridine (20.0 g, 0.103 mol) in acetonitrile (120 mL) followed by sodium iodide (23.3 g, 0.155 mol) and the mixture was heated at reflux with a drying tube fitted for 3 hours. The reaction was cooled in an ice bath, carefully basified with saturated aqueous potassium carbonate then extracted with ethyl acetate (2 x 100 mL). The combined organic layers were washed with saturated aqueous sodium sulfite (200 mL), dried (MgSO4) and evaporated. The residue was then re-submitted to identical reaction and work-up conditions in order to ensure complete reaction and this gave the title compound (18.71 g, 75percent) as a brown solid. 1H NMR (CDCl3, 400 MHz) δ 7.30 (1 H, dd), 7.65 (1 H, d), 8.35 (1 H, d); LRMS (APCI+) 240 [MH+].
Reference: [1] Tetrahedron, 2004, vol. 60, # 51, p. 11869 - 11874
[2] Patent: WO2007/96763, 2007, A2, . Location in patent: Page/Page column 52
[3] Patent: WO2007/15162, 2007, A1, . Location in patent: Page/Page column 91
[4] Patent: US2011/306592, 2011, A1, . Location in patent: Page/Page column 92
  • 16
  • [ 40473-01-6 ]
  • [ 652148-91-9 ]
Reference: [1] Tetrahedron, 2003, vol. 59, # 50, p. 10043 - 10049
  • 17
  • [ 40473-01-6 ]
  • [ 823221-95-0 ]
Reference: [1] Tetrahedron, 2004, vol. 60, # 51, p. 11869 - 11874
[2] Patent: US2011/306592, 2011, A1,
  • 18
  • [ 40473-01-6 ]
  • [ 127-19-5 ]
  • [ 94952-46-2 ]
YieldReaction ConditionsOperation in experiment
85%
Stage #1: With sec.-butyllithium In diethyl ether; hexane at -60℃; for 2 h;
Stage #2: for 3 h;
Stage #3: With hydrogenchloride; water In diethyl ether; hexane
2-Bromo-5-chloropyridine (5.8g, 30mmol) was added to dry diethyl ether (100ml). The mixture was cooled to-60°C and a solution of sec-BuLi (1.4M solution in hexanes, 22mL) was added dropwise and the mixture was stirred for 2hrs. A solution of N, N- dimethylacetamide (3. 1ml, 33mmol) in diethyl ether (20ml) was added slowly dropwise and the solution left to stir for 3hrs. The reaction was brought to room temperature, hydrolysed with 2N HC1 and extracted with DCM. The organic phase was washed with water, dried over MgS04 and evaporated to give 1- (5-Chloro-pyridin-2-yl)-ethanone (4. 0g, 85percent).
59%
Stage #1: With n-butyllithium In diethyl ether; hexane at -78℃;
Stage #2: for 0.5 h;
2) 1-(5-chloro-2-pyridyl)ethanone; A 1.56M solution of n-butyllithium in hexane (27 ml) was added dropwise to a solution of the 2-bromo-5-chloropyridine (6.8 g) in diethylether (45 ml) at-78°C, and thereafter, N,N-dimethyl acetamide (5 ml) was added dropwise to the solution. The mixture was stirred for 30 minutes. To the reaction liquid was added saturated aqueous ammonium chloride and ethyl acetate, and the phases were separated. The organic layer was dried over anhydrous sodium sulfate. After filtration, the solvent was evaporated under reduced pressure, and the residue was purified by column chromatography on silica gel (hexane-ethyl acetate) to give 1-(5-chloro-2-pyridyl)ethanone (3.26 g, 59percent) as a solid. 1H-NMR (400 MHz, CDCl3)δ: 2.70 (3H, s), 7.80 (1H, dd, J = 8.42, 2.32 Hz), 8.00 (1H, d, J = 8.42 Hz), 8.62 (1H, d, J = 2.32 Hz).
59% With n-butyllithium In diethyl ether; hexane at -78℃; for 0.5 h; 2)
1-(5-Chloro-2-pyridyl)ethanone
At -78°C, n-butyllithium (1.56M hexane solution, 27 mL) was added dropwise to 2-bromo-5-chloropyridine (6.8 g) in diethyl ether (45 mL), and then N,N-dimethylacetamide (5 mL) was added dropwise to the resultant mixture, followed by stirring for 30 minutes.
Subsequently, a saturated aqueous solution of ammonium chloride was added to the reaction mixture.
Ethyl acetate was added for partitioning the resultant mixture.
The organic layer was dried over sodium sulfate anhydrate.
After a filtration step, the solvent was evaporated under reduced pressure and the residue was purified by silica gel column chromatography (hexane - ethyl acetate), to thereby give 1-(5-chloro-2-pyridyl)ethanone as a solid product (3.26 g, 59percent).
1H-NMR(400MHz,CDCl3)δ:2.70(3H,s), 7.80(1H,dd,J=8.42,2.32Hz), 8.00(1H,d,J=8.42Hz), 8.62(1H,d,J=2.32Hz).
Reference: [1] Patent: WO2005/92304, 2005, A2, . Location in patent: Page/Page column 43
[2] Patent: EP1698626, 2006, A1, . Location in patent: Page/Page column 41
[3] Patent: EP1762568, 2007, A1, . Location in patent: Page/Page column 25
[4] Patent: US2009/253708, 2009, A1, . Location in patent: Page/Page column 12
  • 19
  • [ 40473-01-6 ]
  • [ 94952-46-2 ]
Reference: [1] Patent: US5622982, 1997, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 40473-01-6 ]

Bromides

Chemical Structure| 65550-77-8

[ 65550-77-8 ]

2-Bromo-5-chloro-3-methylpyridine

Similarity: 0.88

Chemical Structure| 1033203-42-7

[ 1033203-42-7 ]

2-Bromo-4,5-dichloropyridine

Similarity: 0.86

Chemical Structure| 22918-01-0

[ 22918-01-0 ]

2-Bromo-4-chloropyridine

Similarity: 0.81

Chemical Structure| 90902-83-3

[ 90902-83-3 ]

3-Amino-2-bromo-5-chloropyridine

Similarity: 0.81

Chemical Structure| 14482-51-0

[ 14482-51-0 ]

2-Bromo-3,5-dichloropyridine

Similarity: 0.81

Chlorides

Chemical Structure| 65550-77-8

[ 65550-77-8 ]

2-Bromo-5-chloro-3-methylpyridine

Similarity: 0.88

Chemical Structure| 1033203-42-7

[ 1033203-42-7 ]

2-Bromo-4,5-dichloropyridine

Similarity: 0.86

Chemical Structure| 22918-01-0

[ 22918-01-0 ]

2-Bromo-4-chloropyridine

Similarity: 0.81

Chemical Structure| 90902-83-3

[ 90902-83-3 ]

3-Amino-2-bromo-5-chloropyridine

Similarity: 0.81

Chemical Structure| 14482-51-0

[ 14482-51-0 ]

2-Bromo-3,5-dichloropyridine

Similarity: 0.81

Related Parent Nucleus of
[ 40473-01-6 ]

Pyridines

Chemical Structure| 65550-77-8

[ 65550-77-8 ]

2-Bromo-5-chloro-3-methylpyridine

Similarity: 0.88

Chemical Structure| 1033203-42-7

[ 1033203-42-7 ]

2-Bromo-4,5-dichloropyridine

Similarity: 0.86

Chemical Structure| 22918-01-0

[ 22918-01-0 ]

2-Bromo-4-chloropyridine

Similarity: 0.81

Chemical Structure| 90902-83-3

[ 90902-83-3 ]

3-Amino-2-bromo-5-chloropyridine

Similarity: 0.81

Chemical Structure| 14482-51-0

[ 14482-51-0 ]

2-Bromo-3,5-dichloropyridine

Similarity: 0.81